237 related articles for article (PubMed ID: 18446865)
1. Bio-Vision 2016: the second national framework plan for biotechnology promotion in Korea.
Hyeon BH; Kim HY; Lee CM; Moon SH; Kim ES; Lee SY
Biotechnol J; 2008 May; 3(5):591-600. PubMed ID: 18446865
[No Abstract] [Full Text] [Related]
2. Singapore R&D and globetrotting.
Lear MJ; Salmons B; Gunzburg WH; Dangerfield JA
Biotechnol J; 2009 Feb; 4(2):179-85. PubMed ID: 19156748
[No Abstract] [Full Text] [Related]
3. Indian biotechs partner with government.
Jayaraman KS
Nat Biotechnol; 2009 Apr; 27(4):305. PubMed ID: 19352355
[No Abstract] [Full Text] [Related]
4. Malaysia seeks biotech partners.
Aldridge S
Nat Biotechnol; 2009 Apr; 27(4):305. PubMed ID: 19352354
[No Abstract] [Full Text] [Related]
5. International regional collaborations are paying off.
Mitchell P
Nat Biotechnol; 2004 Nov; 22(11):1475. PubMed ID: 15586420
[No Abstract] [Full Text] [Related]
6. Can China bring its own pipeline to the market?
Louët S
Nat Biotechnol; 2004 Dec; 22(12):1497-9. PubMed ID: 15583646
[No Abstract] [Full Text] [Related]
7. Chinese biotech: the need for innovation and higher standards.
Wong GH
Nat Biotechnol; 2006 Feb; 24(2):221-2. PubMed ID: 16465169
[No Abstract] [Full Text] [Related]
8. A voice with no words.
Nat Biotechnol; 2008 Apr; 26(4):358. PubMed ID: 18391996
[No Abstract] [Full Text] [Related]
9. Maturing biotechs turn to pharma's markets.
Ratner M
Nat Biotechnol; 2005 Mar; 23(3):269. PubMed ID: 15765067
[No Abstract] [Full Text] [Related]
10. South Korean biotechnology--a rising industrial and scientific powerhouse.
Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS
Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684
[No Abstract] [Full Text] [Related]
11. Germany reattempts to spark innovation.
Habeck M
Nat Biotechnol; 2004 Mar; 22(3):257-8. PubMed ID: 14990939
[No Abstract] [Full Text] [Related]
12. GlaxoSmithKline pushes its labs towards 'biotech' future.
Adam D
Nature; 2001 Mar; 410(6824):5. PubMed ID: 11242002
[No Abstract] [Full Text] [Related]
13. Biotechnology in South Africa.
Cloete TE; Nel LH; Theron J
Trends Biotechnol; 2006 Dec; 24(12):557-62. PubMed ID: 17070947
[TBL] [Abstract][Full Text] [Related]
14. India's strategy to bridge the public-private divide.
Jayaraman KS
Nat Biotechnol; 2005 May; 23(5):523. PubMed ID: 15942982
[No Abstract] [Full Text] [Related]
15. European research infrastructures for the development of nanobiotechnologies.
Péro H; Faure JE
Trends Biotechnol; 2007 May; 25(5):191-4. PubMed ID: 17368840
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine lacks recognition in Europe.
Moran N
Nat Biotechnol; 2006 Feb; 24(2):121. PubMed ID: 16465142
[No Abstract] [Full Text] [Related]
17. A European biotechnology transfer platform?
Suojanen C
N Biotechnol; 2009 Apr; 25(4):167-8. PubMed ID: 19429530
[No Abstract] [Full Text] [Related]
18. FDA launches two research centers with academia.
Fox JL
Nat Biotechnol; 2014 Jul; 32(7):601. PubMed ID: 25004209
[No Abstract] [Full Text] [Related]
19. Counterpoint: biotech needs more than DTC as usual.
Mack J
Nat Biotechnol; 2006 Mar; 24(3):267. PubMed ID: 16525380
[No Abstract] [Full Text] [Related]
20. Point: Biotech needs direct to consumer communications.
Oestreicher P; Warner T
Nat Biotechnol; 2006 Mar; 24(3):265-6. PubMed ID: 16525378
[No Abstract] [Full Text] [Related]
[Next] [New Search]
